JY
EDIT icon

Jeff Yass’s Editas Medicine EDIT Stock Holding History

Jeff Yass’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
92,845
+19,740
+27% +$57.7K ﹤0.01% 11036
2026
Q1 		$181K Sell
73,105
-631,557
-90% -$1.34M ﹤0.01% 11800
2025
Q4 		$1.44M Sell
704,662
-94,548
-12% -$273K ﹤0.01% 6343
2025
Q3 		$2.77M Sell
799,210
-144,680
-15% -$404K ﹤0.01% 5136
2025
Q2 		$2.08M Buy
943,890
+358,855
+61% +$587K ﹤0.01% 5696
2025
Q1 		$679K Buy
585,035
+144,413
+33% +$212K ﹤0.01% 8222
2024
Q4 		$560K Buy
440,622
+106,399
+32% +$271K ﹤0.01% 8395
2024
Q3 		$1.14M Buy
334,223
+21,026
+7% +$91.5K ﹤0.01% 6481
2024
Q2 		$1.46M Buy
313,197
+102,849
+49% +$580K ﹤0.01% 5733
2024
Q1 		$1.56M Buy
210,348
+142,125
+208% +$1.18M ﹤0.01% 5911
2023
Q4 		$691K Sell
68,223
-278,371
-80% -$2.44M ﹤0.01% 7874
2023
Q3 		$2.7M Buy
346,594
+78,127
+29% +$670K ﹤0.01% 4567
2023
Q2 		$2.21M Buy
268,467
+14,029
+6% +$122K ﹤0.01% 4949
2023
Q1 		$1.84M Buy
254,438
+142,567
+127% +$1.27M ﹤0.01% 5309
2022
Q4 		$992K Sell
111,871
-278,921
-71% -$3.06M ﹤0.01% 6204
2022
Q3 		$4.78M Buy
390,792
+131,693
+51% +$2.05M ﹤0.01% 3225
2022
Q2 		$3.06M Sell
259,099
-49,090
-16% -$658K ﹤0.01% 4031
2022
Q1 		$5.86M Buy
308,189
+42,641
+16% +$793K ﹤0.01% 3367
2021
Q4 		$7.05M Buy
265,548
+48,447
+22% +$1.67M ﹤0.01% 3187
2021
Q3 		$8.92M Sell
217,101
-111,909
-34% -$6.13M ﹤0.01% 3035
2021
Q2 		$18.6M Buy
329,010
+154,140
+88% +$5.69M ﹤0.01% 2124
2021
Q1 		$7.34M Buy
174,870
+101,877
+140% +$5.8M ﹤0.01% 3266
2020
Q4 		$5.12M Sell
72,993
-63,265
-46% -$2.6M ﹤0.01% 3387
2020
Q3 		$3.82M Sell
136,258
-95,321
-41% -$3.1M ﹤0.01% 3455
2020
Q2 		$6.85M Buy
231,579
+17,713
+8% +$463K ﹤0.01% 2598
2020
Q1 		$4.24M Sell
213,866
-76,779
-26% -$1.94M ﹤0.01% 2793
2019
Q4 		$8.61M Buy
290,645
+97,398
+50% +$2.43M ﹤0.01% 2254
2019
Q3 		$4.39M Sell
193,247
-77,463
-29% -$1.92M ﹤0.01% 2905
2019
Q2 		$6.7M Buy
270,710
+94,779
+54% +$2.26M ﹤0.01% 2347
2019
Q1 		$4.3M Sell
175,931
-146,476
-45% -$3.32M ﹤0.01% 2635
2018
Q4 		$7.33M Buy
322,407
+155,358
+93% +$4.23M ﹤0.01% 1887
2018
Q3 		$5.32M Sell
167,049
-19,125
-10% -$618K ﹤0.01% 2616
2018
Q2 		$6.67M Buy
186,174
+63,150
+51% +$2.24M ﹤0.01% 2389
2018
Q1 		$4.08M Sell
123,024
-93,882
-43% -$3.35M ﹤0.01% 2797
2017
Q4 		$6.67M Buy
+216,906
New +$5.46M ﹤0.01% 2210
2017
Q3 		– Sell
-19,051
Closed -$363K – 8976
2017
Q2 		$320K Sell
19,051
-145,093
-88% -$2.61M ﹤0.01% 7464
2017
Q1 		$3.66M Buy
164,144
+129,435
+373% +$2.68M ﹤0.01% 2730
2016
Q4 		$563K Buy
+34,709
New +$527K ﹤0.01% 6732

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jeff Yass's EDIT Position: Q2 2026 in Review

Jeff Yass increased its Editas Medicine (EDIT) stake by 27% in Q2 2026, buying an estimated $57.7K and bringing the position to 92,845 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #11036.

Jeff Yass first reported a position in EDIT in Q4 2016 and has held it in 38 quarters since. The position peaked at $18.6M in Q2 2021. 213 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Jeff Yass held 92,845 shares of Editas Medicine worth $301K as of Q2 2026.
  • Jeff Yass bought 19,740 Editas Medicine shares in Q2 2026, an estimated $57.7K.
  • Editas Medicine made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11036 holding.
  • Jeff Yass first reported a position in Editas Medicine in Q4 2016 and has held it in 38 quarters since.
  • Jeff Yass's Editas Medicine position peaked at $18.6M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.